Xu Shi
- Topics
- Ferroptosis and cancer prognosis (14 papers)Cancer, Hypoxia, and Metabolism (5 papers)Epigenetics and DNA Methylation (5 papers)
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Xu Shi
24 papers receiving 316 citations
Peers
Comparison fields: 5 of 48
- Pulmonary and Respiratory Medicine 165
- Cancer Research 153
- Molecular Biology 146
- Oncology 58
- Immunology 44
Countries citing papers authored by Xu Shi
This map shows the geographic impact of Xu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Shi more than expected).
Fields of papers citing papers by Xu Shi
This network shows the impact of papers produced by Xu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Shi. The network helps show where Xu Shi may publish in the future.
Co-authorship network of co-authors of Xu Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Xu Shi. A scholar is included among the top collaborators of Xu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Shi. Xu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 38 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer | 14 |
| 7 | 5 | |
| 8 | 23 | |
| 9 | 23 | |
| 10 | 11 | |
| 11 | 6 | |
| 12 | 9 | |
| 13 | 28 | |
| 14 | 16 | |
| 15 | 16 | |
| 16 | 17 | |
| 17 | 15 | |
| 18 | 16 | |
| 19 | 4 | |
| 20 | 15 |
About Xu Shi
Xu Shi is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 24 papers that have together received 316 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (14 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (153 citations), Pulmonary and Respiratory Medicine (165 citations) and Endocrine and Autonomic Systems (30 citations). Xu Shi has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Dechao Feng, Qiao Xiong, Lu Yang, Qiang Wei, Facai Zhang, Dengxiong Li, Wuran Wei, Jia You, Jie Wang and Ping Han. Their work appears in journals such as Frontiers in Immunology, Molecules and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.